Drugs / Palifosfamide
Palifosfamide
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00421135 | Feb 2006 → Oct 2007 | cancer of unknown primary site | Alaunos Therapeutics | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00439686 | Feb 2006 → Jun 2008 | sarcoma | Alaunos Therapeutics | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT01703754 | Apr 2013 → Aug 2014 | breast carcinoma | Alaunos Therapeutics | Terminated | No outcome recorded |
| Phase 2 | NCT01808534 | Feb 2013 → Nov 2014 | adult central nervous system germ cell tumor, adult teratoma, extragonadal nonseminomatous germ cell tumor, extragonadal seminoma +2 | Indiana University | Terminated | No outcome recorded |
| Phase 2 | NCT00718484 | Aug 2008 → Apr 2012 | soft tissue sarcoma | Alaunos Therapeutics | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01168791 | Jul 2010 → Mar 2013 | soft tissue sarcoma | Alaunos Therapeutics | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Palifosfamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00718484 ↗ |
| Known as | IPM | “A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer” NCT00421135 ↗ |
| Known as | Isophosphoramide Mustard | “A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer” NCT00421135 ↗ |
| Known as | Isophosporamide Mustard | “A Phase IB/IIA Study of the Saftey and Activity of Intravenous Isophosporamide Mustard (ZIO-201) in Patients With Advanced Sarcoma” NCT00439686 ↗ |
| Known as | ZIO-201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00439686 ↗ |
| Modality | Small molecule | “Small molecule chemotherapy, IV administration” NCT01703754 ↗ |
| Route | Intravenous | “Intravenous Isophosphoramide Mustard (IPM)” NCT00421135 ↗ |